Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
misiu143's Profile
Displaying 3051-3100 of 4584 result(s).
CYDY CytoDyn Inc
06/11/2019 6:35:04 AM
I also avoid them for my family and
CYDY CytoDyn Inc
06/10/2019 9:32:22 PM
PET/CT test is a very good test , b
CYDY CytoDyn Inc
06/10/2019 8:58:18 PM
Post on the other board about Human
CYDY CytoDyn Inc
06/10/2019 2:58:10 PM
This is what I posted here when the
CYDY CytoDyn Inc
06/10/2019 12:20:30 PM
I will not be trying to convince an (1)
CYDY CytoDyn Inc
06/10/2019 9:37:31 AM
And one more thing , as we talked i (1)
CYDY CytoDyn Inc
06/10/2019 9:15:36 AM
Yes , but with cancers like TNBC im
CYDY CytoDyn Inc
06/08/2019 11:18:50 PM
Trding , - I am not sure if those p
CYDY CytoDyn Inc
06/08/2019 11:04:00 PM
I am not as sure as you are ... You
CYDY CytoDyn Inc
06/08/2019 1:07:37 PM
I dont believe that TNBC can be app
CYDY CytoDyn Inc
06/08/2019 12:22:23 PM
I believe it is a very good buy for (1)
CYDY CytoDyn Inc
06/08/2019 12:00:43 PM
Generally FDA like to see 2 months
CYDY CytoDyn Inc
06/08/2019 11:47:43 AM
Haha ...Trding , you are genius , i
CYDY CytoDyn Inc
06/08/2019 11:26:25 AM
There are drugs approved in unusual
CYDY CytoDyn Inc
06/08/2019 9:25:28 AM
Trding , I kind of knew this will h
CYDY CytoDyn Inc
06/08/2019 9:23:51 AM
If results will be VERY positive in (1)
CYDY CytoDyn Inc
06/08/2019 8:28:28 AM
I just answered Amatuer post on the
CYDY CytoDyn Inc
06/07/2019 4:48:56 PM
It is really easy mistake , before
CYDY CytoDyn Inc
06/07/2019 3:16:05 PM
It is funny..:))
CYDY CytoDyn Inc
06/07/2019 2:50:33 PM
Probably someone confused Vancouver
CYDY CytoDyn Inc
06/07/2019 2:45:50 PM
yes... at 1:50-2:30 Dr NP is talkin
CYDY CytoDyn Inc
06/07/2019 2:09:38 PM
Probably you are right , this is mo
CYDY CytoDyn Inc
06/07/2019 1:45:43 PM
Plavac , very good , I forgot to wr
CYDY CytoDyn Inc
06/07/2019 1:27:47 PM
Today interview :.., 0:35 FDA want (1)
CYDY CytoDyn Inc
06/07/2019 12:32:13 PM
Trding , I just looked at your char (1)
CYDY CytoDyn Inc
06/07/2019 7:37:58 AM
IMO , if results are good in phase (1)
CYDY CytoDyn Inc
06/07/2019 7:27:58 AM
Yes , even if doctor will want to u
CYDY CytoDyn Inc
06/07/2019 7:02:15 AM
I like this study very much , for C
CYDY CytoDyn Inc
06/07/2019 6:48:07 AM
We talked about it in the past , an
CYDY CytoDyn Inc
06/06/2019 5:45:45 PM
Ibalizumab is 118,000 a year, plus
CYDY CytoDyn Inc
06/06/2019 3:18:24 PM
Yes , let’s inject those patients
CYDY CytoDyn Inc
06/06/2019 2:30:41 PM
PS... we just don’t know if impro
CYDY CytoDyn Inc
06/06/2019 1:54:05 PM
SJ ..lol ... I too don’t care wit
CYDY CytoDyn Inc
06/06/2019 1:21:03 PM
I couldn’t understand well with w
CYDY CytoDyn Inc
06/06/2019 1:07:58 PM
Maybe , but then they will not open
CYDY CytoDyn Inc
06/06/2019 12:41:36 PM
At this point I don’t understand
CYDY CytoDyn Inc
06/06/2019 11:17:07 AM
First 3 points should happen withou
CYDY CytoDyn Inc
06/06/2019 11:15:37 AM
On the slide it still show over 740
CYDY CytoDyn Inc
06/05/2019 8:44:56 AM
Trding,after listening to last nigh
CYDY CytoDyn Inc
06/05/2019 2:37:04 AM
I listened again , so the vision as
CYDY CytoDyn Inc
06/05/2019 2:09:20 AM
New video on with proactive investo (2)
CYDY CytoDyn Inc
06/04/2019 5:42:10 PM
I agree with you ,....... Maraviroc (1)
CYDY CytoDyn Inc
06/04/2019 7:06:10 AM
Not sure if this is complete explan
CYDY CytoDyn Inc
06/03/2019 8:12:48 PM
SJ - I know only that CAR-T therapy
CYDY CytoDyn Inc
06/03/2019 5:47:51 PM
I just noticed that my article is o
CYDY CytoDyn Inc
06/03/2019 5:18:21 PM
Thank you Zuess.
CYDY CytoDyn Inc
06/03/2019 5:01:00 PM
As soon we think we know a lot , ne
CYDY CytoDyn Inc
06/02/2019 2:21:18 PM
CCR5 is expressed in over 50% of al
CYDY CytoDyn Inc
06/02/2019 12:36:49 AM
After 3.5 years 70% survival from 4
CYDY CytoDyn Inc
06/01/2019 4:22:42 PM
Yes , angiogenesis is very importan
Go to page:
  • << First
  • < Previous
  • 61
  • 62
  • Next >

Recent Articles

  • Broadstreet to Administer Allivate’s New Employee Ownership Fund
  • uBreakiFix Expands Franchise with Spokane Location Opening
  • Insights on American Social Safety Net and COVID Policy Shifts
  • Rooftop Rainwater Systems: A Sustainable Solution for Homes
  • Gregory M. Yaffa Joins Esteemed American Board of Trial Advocates
  • Insights into IPSEN's Ongoing Share Buy-back Program Details
  • Terra Innovatum's Historic Deal Paves Way for Sustainable Energy
  • Danone Reveals Key Voting Rights and Shareholder Information
  • GCC Plans Earnings Call to Discuss Q3 2025 Performance
  • Shell's Key Share Buyback Strategies and Financial Insights
  • Azerion Group N.V. Announces Redemption of Senior Bonds
  • Celebrating Innovation: Hagersville Battery Storage Award Win
  • Luxury Living Redefined at Toll Brothers' New Community
  • Burlington Stores: A Decade of Impressive Investment Growth
  • NVIDIA's Rise: A Game Changer for Global Equity Markets
  • JPMorgan's Dynamic Leadership Shift in EMEA Region
  • The Cost-Effective Benefits of Power Washing for Properties
  • Rubin Rudman Welcomes Kelly Aylward as Trusts & Estates Partner
  • Independent Financial Group Expands with New Advisors and Firm
  • Important Shareholder Investigations: VECO, WOW, and CCRD Insights
  • Investigation by Halper Sadeh LLC: Securities Violations Alert
  • Winter's Majesty: Join the World Snow Celebration 2026
  • NeXtGen Biologics Secures New Patent for Innovative Technology
  • Launching the Dynamic Desmadre Live! Culture Show for All
  • Rigetti Computing's Market Movement and Analyst Insights
  • Five-Year Investment Journey with IBM: What to Expect
  • Mark Cuban's Bold Critique on U.S. Healthcare Landscape
  • Gold's Surge and Market Dynamics: A Comprehensive Analysis
  • IREN Limited: Recent Stock Movements and Future Prospects
  • Chomps Expands Its Reach with Innovative Business Strategies
  • Understanding Baker Hughes P/E Ratio and Market Position
  • Shutterstock Expands AI Services for Enhanced Model Development
  • Exploring Seagate Technology Holdings: Options Market Insights
  • PetLab Co. Revolutionizes Pet Health with Innovative Strategies
  • Analyzing the Latest Unusual Options Trends for Starbucks
  • Empowering California Students Through College Track Partnership
  • Eli Lilly's Options Activity Insights: What Investors Should Know
  • FinTech Magazine's Insightful 2025 Industry Report Released
  • Transformative AI Features Unveiled in NetSuite Next Release
  • BNB Overtakes XRP and USDT to Claim 3rd Spot in Crypto
  • Galderma Ad Claims Reviewed: Recommendations for Changes
  • How Television Can Transform End-of-Life Conversations
  • S&P Global Innovative Index Revolutionizes Crypto Investment Approach
  • BERO Brewing Leverages Technology for Global Expansion
  • Antero Resources Stock: Profiting from Five Years of Growth
  • Instacart Unveils Cutting-Edge Retail Media Partnership with TikTok
  • Why Take-Two Interactive is Poised for Growth Amid Industry Changes
  • Apollo GraphQL Introduces Major Enhancements for AI Integration
  • HEI Civil’s Commitment Shines with Safety Award Recognition
  • Explore the Cutting-Edge AI Innovations in SuiteCloud
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site